Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents

K. W. Pankiewicz

Research output: Contribution to journalReview articlepeer-review

20 Scopus citations


Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme which controls de novo synthesis of purine nucleotides, is an important target for the development of chemotherapeutic agents. The concentration of IMPDH was found to increase in tumour cells and activated lymphocytes. Thus, inhibition of IMPDH would result in anticancer and immunosuppressive activities. Since there is an increased demand for purine nucleotides in virus infected cells needed for RNA and DNA synthesis, inhibition of IMPDH may also lead to antiviral activity. IMPDHs from bacteria, parasites and mammalian sources differ significantly. Such differences can be exploited for the development of antibacterial or antiparasitic agents. Recent progress in revealing the molecular structure, mechanism of action and interactions of the enzyme with the co-factor and inhibitors provided a new stimulus for the development of novel agents targeted against IMPDH. This review covers both academic and industrial studies aimed at inhibition of IMPDH.

Original languageEnglish (US)
Pages (from-to)55-65
Number of pages11
JournalExpert Opinion on Therapeutic Patents
Issue number1
StatePublished - 1999
Externally publishedYes


  • Antiviral
  • Cancer
  • Chemotherapy
  • Immunosuppression
  • Inosine monophosphate dehydrogenase


Dive into the research topics of 'Inhibitors of inosine monophosphate dehydrogenase as potential chemotherapeutic agents'. Together they form a unique fingerprint.

Cite this